nodes	percent_of_prediction	percent_of_DWPC	metapath
Brinzolamide—CA4—epilepsy syndrome	0.242	1	CbGaD
Brinzolamide—CA14—Lacosamide—epilepsy syndrome	0.0272	0.0504	CbGbCtD
Brinzolamide—CA6—Lacosamide—epilepsy syndrome	0.0258	0.0479	CbGbCtD
Brinzolamide—CA5B—Lacosamide—epilepsy syndrome	0.0225	0.0417	CbGbCtD
Brinzolamide—CA9—Lacosamide—epilepsy syndrome	0.0193	0.0358	CbGbCtD
Brinzolamide—CA14—Acetazolamide—epilepsy syndrome	0.0187	0.0347	CbGbCtD
Brinzolamide—CA1—Lacosamide—epilepsy syndrome	0.018	0.0335	CbGbCtD
Brinzolamide—CA6—Acetazolamide—epilepsy syndrome	0.0178	0.033	CbGbCtD
Brinzolamide—CA5A—Acetazolamide—epilepsy syndrome	0.0178	0.033	CbGbCtD
Brinzolamide—CA14—Zonisamide—epilepsy syndrome	0.0173	0.0321	CbGbCtD
Brinzolamide—CA4—Lacosamide—epilepsy syndrome	0.017	0.0315	CbGbCtD
Brinzolamide—CA6—Zonisamide—epilepsy syndrome	0.0164	0.0305	CbGbCtD
Brinzolamide—CA5A—Zonisamide—epilepsy syndrome	0.0164	0.0305	CbGbCtD
Brinzolamide—CA2—Lacosamide—epilepsy syndrome	0.0156	0.029	CbGbCtD
Brinzolamide—CA7—Acetazolamide—epilepsy syndrome	0.0155	0.0287	CbGbCtD
Brinzolamide—CA5B—Acetazolamide—epilepsy syndrome	0.0155	0.0287	CbGbCtD
Brinzolamide—CA5B—Zonisamide—epilepsy syndrome	0.0143	0.0266	CbGbCtD
Brinzolamide—CA7—Zonisamide—epilepsy syndrome	0.0143	0.0266	CbGbCtD
Brinzolamide—CA12—Acetazolamide—epilepsy syndrome	0.0133	0.0246	CbGbCtD
Brinzolamide—CA9—Acetazolamide—epilepsy syndrome	0.0133	0.0246	CbGbCtD
Brinzolamide—CA1—Acetazolamide—epilepsy syndrome	0.0124	0.0231	CbGbCtD
Brinzolamide—CA12—Zonisamide—epilepsy syndrome	0.0123	0.0228	CbGbCtD
Brinzolamide—CA9—Zonisamide—epilepsy syndrome	0.0123	0.0228	CbGbCtD
Brinzolamide—CA5A—Topiramate—epilepsy syndrome	0.012	0.0222	CbGbCtD
Brinzolamide—CA6—Topiramate—epilepsy syndrome	0.012	0.0222	CbGbCtD
Brinzolamide—CA4—Acetazolamide—epilepsy syndrome	0.0117	0.0217	CbGbCtD
Brinzolamide—CA1—Zonisamide—epilepsy syndrome	0.0115	0.0213	CbGbCtD
Brinzolamide—CA4—Zonisamide—epilepsy syndrome	0.0108	0.0201	CbGbCtD
Brinzolamide—CA2—Acetazolamide—epilepsy syndrome	0.0107	0.0199	CbGbCtD
Brinzolamide—CA7—Topiramate—epilepsy syndrome	0.0104	0.0194	CbGbCtD
Brinzolamide—CA5B—Topiramate—epilepsy syndrome	0.0104	0.0194	CbGbCtD
Brinzolamide—CA2—Zonisamide—epilepsy syndrome	0.00993	0.0184	CbGbCtD
Brinzolamide—CA9—Topiramate—epilepsy syndrome	0.00895	0.0166	CbGbCtD
Brinzolamide—CA12—Topiramate—epilepsy syndrome	0.00895	0.0166	CbGbCtD
Brinzolamide—CA1—Topiramate—epilepsy syndrome	0.00838	0.0155	CbGbCtD
Brinzolamide—CA4—Topiramate—epilepsy syndrome	0.00788	0.0146	CbGbCtD
Brinzolamide—CA2—Topiramate—epilepsy syndrome	0.00724	0.0134	CbGbCtD
Brinzolamide—CA6—ear—epilepsy syndrome	0.00328	0.156	CbGeAlD
Brinzolamide—CYP3A4—Oxcarbazepine—epilepsy syndrome	0.0022	0.00408	CbGbCtD
Brinzolamide—Dorzolamide—CA4—epilepsy syndrome	0.00206	1	CrCbGaD
Brinzolamide—CYP3A4—Trimethadione—epilepsy syndrome	0.00204	0.00379	CbGbCtD
Brinzolamide—CYP3A4—Felbamate—epilepsy syndrome	0.00204	0.00379	CbGbCtD
Brinzolamide—CYP3A4—Fosphenytoin—epilepsy syndrome	0.00192	0.00356	CbGbCtD
Brinzolamide—CYP3A4—Clonazepam—epilepsy syndrome	0.00174	0.00322	CbGbCtD
Brinzolamide—CYP3A4—Clobazam—epilepsy syndrome	0.00166	0.00309	CbGbCtD
Brinzolamide—CYP3A4—Rufinamide—epilepsy syndrome	0.00142	0.00263	CbGbCtD
Brinzolamide—CYP3A4—Carbamazepine—epilepsy syndrome	0.00138	0.00256	CbGbCtD
Brinzolamide—CYP3A4—Primidone—epilepsy syndrome	0.00129	0.00239	CbGbCtD
Brinzolamide—CYP3A4—Phenytoin—epilepsy syndrome	0.00124	0.0023	CbGbCtD
Brinzolamide—CYP3A4—Propofol—epilepsy syndrome	0.00115	0.00214	CbGbCtD
Brinzolamide—CYP3A4—Acetazolamide—epilepsy syndrome	0.0011	0.00205	CbGbCtD
Brinzolamide—CYP3A4—Phenobarbital—epilepsy syndrome	0.0011	0.00205	CbGbCtD
Brinzolamide—CYP3A4—Midazolam—epilepsy syndrome	0.00109	0.00202	CbGbCtD
Brinzolamide—CYP3A4—Diazepam—epilepsy syndrome	0.00105	0.00194	CbGbCtD
Brinzolamide—CYP3A4—Zonisamide—epilepsy syndrome	0.00102	0.00189	CbGbCtD
Brinzolamide—CA4—ganglion—epilepsy syndrome	0.000848	0.0404	CbGeAlD
Brinzolamide—CYP3A4—Valproic Acid—epilepsy syndrome	0.000824	0.00153	CbGbCtD
Brinzolamide—CYP3A4—Topiramate—epilepsy syndrome	0.000743	0.00138	CbGbCtD
Brinzolamide—CA14—telencephalon—epilepsy syndrome	0.000677	0.0322	CbGeAlD
Brinzolamide—CA4—hindbrain—epilepsy syndrome	0.000643	0.0306	CbGeAlD
Brinzolamide—CA7—midbrain—epilepsy syndrome	0.000584	0.0278	CbGeAlD
Brinzolamide—CA12—forebrain—epilepsy syndrome	0.000574	0.0273	CbGeAlD
Brinzolamide—CA2—hindbrain—epilepsy syndrome	0.000533	0.0254	CbGeAlD
Brinzolamide—CA14—medulla oblongata—epilepsy syndrome	0.000532	0.0253	CbGeAlD
Brinzolamide—CA12—telencephalon—epilepsy syndrome	0.000528	0.0251	CbGeAlD
Brinzolamide—CA6—head—epilepsy syndrome	0.00049	0.0234	CbGeAlD
Brinzolamide—CA14—midbrain—epilepsy syndrome	0.000486	0.0232	CbGeAlD
Brinzolamide—CA14—spinal cord—epilepsy syndrome	0.000474	0.0226	CbGeAlD
Brinzolamide—CA1—forebrain—epilepsy syndrome	0.000455	0.0217	CbGeAlD
Brinzolamide—CA7—cerebellum—epilepsy syndrome	0.000452	0.0215	CbGeAlD
Brinzolamide—CA1—telencephalon—epilepsy syndrome	0.000418	0.0199	CbGeAlD
Brinzolamide—CA9—cerebellum—epilepsy syndrome	0.000397	0.0189	CbGeAlD
Brinzolamide—CA14—cerebellum—epilepsy syndrome	0.000376	0.0179	CbGeAlD
Brinzolamide—CA4—brainstem—epilepsy syndrome	0.000368	0.0175	CbGeAlD
Brinzolamide—CA7—brain—epilepsy syndrome	0.000367	0.0175	CbGeAlD
Brinzolamide—CA4—forebrain—epilepsy syndrome	0.000356	0.0169	CbGeAlD
Brinzolamide—CA12—head—epilepsy syndrome	0.000329	0.0157	CbGeAlD
Brinzolamide—CA4—telencephalon—epilepsy syndrome	0.000327	0.0156	CbGeAlD
Brinzolamide—CA12—nervous system—epilepsy syndrome	0.000312	0.0148	CbGeAlD
Brinzolamide—CA14—brain—epilepsy syndrome	0.000306	0.0146	CbGeAlD
Brinzolamide—CA2—brainstem—epilepsy syndrome	0.000305	0.0145	CbGeAlD
Brinzolamide—CA12—central nervous system—epilepsy syndrome	0.0003	0.0143	CbGeAlD
Brinzolamide—CA5B—head—epilepsy syndrome	0.000295	0.014	CbGeAlD
Brinzolamide—CA2—forebrain—epilepsy syndrome	0.000295	0.014	CbGeAlD
Brinzolamide—CA1—spinal cord—epilepsy syndrome	0.000293	0.014	CbGeAlD
Brinzolamide—CA5B—nervous system—epilepsy syndrome	0.00028	0.0133	CbGeAlD
Brinzolamide—CA2—telencephalon—epilepsy syndrome	0.000271	0.0129	CbGeAlD
Brinzolamide—CA5B—central nervous system—epilepsy syndrome	0.000269	0.0128	CbGeAlD
Brinzolamide—CA1—head—epilepsy syndrome	0.00026	0.0124	CbGeAlD
Brinzolamide—CA4—medulla oblongata—epilepsy syndrome	0.000257	0.0122	CbGeAlD
Brinzolamide—CA1—nervous system—epilepsy syndrome	0.000247	0.0118	CbGeAlD
Brinzolamide—CA12—brain—epilepsy syndrome	0.000238	0.0113	CbGeAlD
Brinzolamide—CA1—central nervous system—epilepsy syndrome	0.000238	0.0113	CbGeAlD
Brinzolamide—CA4—midbrain—epilepsy syndrome	0.000235	0.0112	CbGeAlD
Brinzolamide—CA4—spinal cord—epilepsy syndrome	0.000229	0.0109	CbGeAlD
Brinzolamide—CA5B—brain—epilepsy syndrome	0.000214	0.0102	CbGeAlD
Brinzolamide—CA2—medulla oblongata—epilepsy syndrome	0.000213	0.0101	CbGeAlD
Brinzolamide—CA4—head—epilepsy syndrome	0.000204	0.0097	CbGeAlD
Brinzolamide—CA2—midbrain—epilepsy syndrome	0.000195	0.00927	CbGeAlD
Brinzolamide—CA4—nervous system—epilepsy syndrome	0.000193	0.00919	CbGeAlD
Brinzolamide—CA2—spinal cord—epilepsy syndrome	0.00019	0.00905	CbGeAlD
Brinzolamide—CA1—brain—epilepsy syndrome	0.000189	0.00899	CbGeAlD
Brinzolamide—CA4—central nervous system—epilepsy syndrome	0.000186	0.00885	CbGeAlD
Brinzolamide—CA4—cerebellum—epilepsy syndrome	0.000182	0.00865	CbGeAlD
Brinzolamide—CA2—head—epilepsy syndrome	0.000169	0.00804	CbGeAlD
Brinzolamide—CA2—nervous system—epilepsy syndrome	0.00016	0.00762	CbGeAlD
Brinzolamide—CA2—central nervous system—epilepsy syndrome	0.000154	0.00734	CbGeAlD
Brinzolamide—CA2—cerebellum—epilepsy syndrome	0.000151	0.00717	CbGeAlD
Brinzolamide—CA4—brain—epilepsy syndrome	0.000148	0.00703	CbGeAlD
Brinzolamide—CA2—brain—epilepsy syndrome	0.000122	0.00583	CbGeAlD
Brinzolamide—CYP3A4—nervous system—epilepsy syndrome	0.000103	0.00492	CbGeAlD
Brinzolamide—CYP3A4—central nervous system—epilepsy syndrome	9.94e-05	0.00473	CbGeAlD
Brinzolamide—Dizziness—Diazepam—epilepsy syndrome	3.69e-05	0.000291	CcSEcCtD
Brinzolamide—Infection—Valproic Acid—epilepsy syndrome	3.68e-05	0.000291	CcSEcCtD
Brinzolamide—Rash—Fosphenytoin—epilepsy syndrome	3.66e-05	0.000289	CcSEcCtD
Brinzolamide—Dermatitis—Fosphenytoin—epilepsy syndrome	3.66e-05	0.000289	CcSEcCtD
Brinzolamide—Nervousness—Gabapentin—epilepsy syndrome	3.66e-05	0.000289	CcSEcCtD
Brinzolamide—Asthenia—Clonazepam—epilepsy syndrome	3.65e-05	0.000289	CcSEcCtD
Brinzolamide—Rhinitis—Topiramate—epilepsy syndrome	3.65e-05	0.000288	CcSEcCtD
Brinzolamide—Back pain—Gabapentin—epilepsy syndrome	3.64e-05	0.000288	CcSEcCtD
Brinzolamide—Headache—Fosphenytoin—epilepsy syndrome	3.64e-05	0.000288	CcSEcCtD
Brinzolamide—Nervous system disorder—Valproic Acid—epilepsy syndrome	3.64e-05	0.000287	CcSEcCtD
Brinzolamide—Palpitations—Pregabalin—epilepsy syndrome	3.63e-05	0.000287	CcSEcCtD
Brinzolamide—Asthenia—Phenytoin—epilepsy syndrome	3.63e-05	0.000287	CcSEcCtD
Brinzolamide—Nausea—Midazolam—epilepsy syndrome	3.62e-05	0.000286	CcSEcCtD
Brinzolamide—Hypoaesthesia—Topiramate—epilepsy syndrome	3.62e-05	0.000286	CcSEcCtD
Brinzolamide—Muscle spasms—Gabapentin—epilepsy syndrome	3.62e-05	0.000286	CcSEcCtD
Brinzolamide—Tachycardia—Valproic Acid—epilepsy syndrome	3.62e-05	0.000286	CcSEcCtD
Brinzolamide—Diarrhoea—Zonisamide—epilepsy syndrome	3.61e-05	0.000286	CcSEcCtD
Brinzolamide—Pharyngitis—Topiramate—epilepsy syndrome	3.61e-05	0.000285	CcSEcCtD
Brinzolamide—Asthenia—Oxcarbazepine—epilepsy syndrome	3.61e-05	0.000285	CcSEcCtD
Brinzolamide—Pruritus—Clonazepam—epilepsy syndrome	3.6e-05	0.000285	CcSEcCtD
Brinzolamide—Vomiting—Vigabatrin—epilepsy syndrome	3.6e-05	0.000284	CcSEcCtD
Brinzolamide—Skin disorder—Valproic Acid—epilepsy syndrome	3.6e-05	0.000284	CcSEcCtD
Brinzolamide—Urinary tract disorder—Topiramate—epilepsy syndrome	3.59e-05	0.000284	CcSEcCtD
Brinzolamide—Oedema peripheral—Topiramate—epilepsy syndrome	3.59e-05	0.000283	CcSEcCtD
Brinzolamide—Cough—Pregabalin—epilepsy syndrome	3.58e-05	0.000283	CcSEcCtD
Brinzolamide—Pruritus—Phenytoin—epilepsy syndrome	3.58e-05	0.000283	CcSEcCtD
Brinzolamide—Connective tissue disorder—Topiramate—epilepsy syndrome	3.58e-05	0.000283	CcSEcCtD
Brinzolamide—Nausea—Levetiracetam—epilepsy syndrome	3.58e-05	0.000283	CcSEcCtD
Brinzolamide—Rash—Vigabatrin—epilepsy syndrome	3.57e-05	0.000282	CcSEcCtD
Brinzolamide—Dizziness—Felbamate—epilepsy syndrome	3.57e-05	0.000282	CcSEcCtD
Brinzolamide—Dermatitis—Vigabatrin—epilepsy syndrome	3.57e-05	0.000282	CcSEcCtD
Brinzolamide—Urethral disorder—Topiramate—epilepsy syndrome	3.57e-05	0.000282	CcSEcCtD
Brinzolamide—Pruritus—Oxcarbazepine—epilepsy syndrome	3.56e-05	0.000281	CcSEcCtD
Brinzolamide—Hypersensitivity—Carbamazepine—epilepsy syndrome	3.56e-05	0.000281	CcSEcCtD
Brinzolamide—Vision blurred—Gabapentin—epilepsy syndrome	3.55e-05	0.00028	CcSEcCtD
Brinzolamide—Headache—Vigabatrin—epilepsy syndrome	3.55e-05	0.00028	CcSEcCtD
Brinzolamide—Hypertension—Pregabalin—epilepsy syndrome	3.55e-05	0.00028	CcSEcCtD
Brinzolamide—Vomiting—Diazepam—epilepsy syndrome	3.55e-05	0.00028	CcSEcCtD
Brinzolamide—Tremor—Gabapentin—epilepsy syndrome	3.53e-05	0.000279	CcSEcCtD
Brinzolamide—Rash—Diazepam—epilepsy syndrome	3.52e-05	0.000278	CcSEcCtD
Brinzolamide—Dermatitis—Diazepam—epilepsy syndrome	3.51e-05	0.000277	CcSEcCtD
Brinzolamide—Visual impairment—Topiramate—epilepsy syndrome	3.51e-05	0.000277	CcSEcCtD
Brinzolamide—Myalgia—Pregabalin—epilepsy syndrome	3.5e-05	0.000276	CcSEcCtD
Brinzolamide—Arthralgia—Pregabalin—epilepsy syndrome	3.5e-05	0.000276	CcSEcCtD
Brinzolamide—Chest pain—Pregabalin—epilepsy syndrome	3.5e-05	0.000276	CcSEcCtD
Brinzolamide—Ill-defined disorder—Gabapentin—epilepsy syndrome	3.49e-05	0.000276	CcSEcCtD
Brinzolamide—Dizziness—Zonisamide—epilepsy syndrome	3.49e-05	0.000276	CcSEcCtD
Brinzolamide—Headache—Diazepam—epilepsy syndrome	3.49e-05	0.000276	CcSEcCtD
Brinzolamide—Diarrhoea—Clonazepam—epilepsy syndrome	3.48e-05	0.000275	CcSEcCtD
Brinzolamide—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	3.47e-05	0.000274	CcSEcCtD
Brinzolamide—Hypotension—Valproic Acid—epilepsy syndrome	3.46e-05	0.000274	CcSEcCtD
Brinzolamide—Asthenia—Carbamazepine—epilepsy syndrome	3.46e-05	0.000274	CcSEcCtD
Brinzolamide—Agitation—Gabapentin—epilepsy syndrome	3.46e-05	0.000273	CcSEcCtD
Brinzolamide—Diarrhoea—Phenytoin—epilepsy syndrome	3.46e-05	0.000273	CcSEcCtD
Brinzolamide—Discomfort—Pregabalin—epilepsy syndrome	3.45e-05	0.000273	CcSEcCtD
Brinzolamide—Nausea—Fosphenytoin—epilepsy syndrome	3.45e-05	0.000273	CcSEcCtD
Brinzolamide—Diarrhoea—Oxcarbazepine—epilepsy syndrome	3.44e-05	0.000272	CcSEcCtD
Brinzolamide—Hypersensitivity—Lamotrigine—epilepsy syndrome	3.44e-05	0.000272	CcSEcCtD
Brinzolamide—Vomiting—Felbamate—epilepsy syndrome	3.43e-05	0.000271	CcSEcCtD
Brinzolamide—Dry mouth—Pregabalin—epilepsy syndrome	3.42e-05	0.00027	CcSEcCtD
Brinzolamide—Pruritus—Carbamazepine—epilepsy syndrome	3.42e-05	0.00027	CcSEcCtD
Brinzolamide—Rash—Felbamate—epilepsy syndrome	3.4e-05	0.000269	CcSEcCtD
Brinzolamide—Eye disorder—Topiramate—epilepsy syndrome	3.4e-05	0.000269	CcSEcCtD
Brinzolamide—Dermatitis—Felbamate—epilepsy syndrome	3.4e-05	0.000269	CcSEcCtD
Brinzolamide—Malaise—Gabapentin—epilepsy syndrome	3.4e-05	0.000268	CcSEcCtD
Brinzolamide—Tinnitus—Topiramate—epilepsy syndrome	3.39e-05	0.000268	CcSEcCtD
Brinzolamide—Vertigo—Gabapentin—epilepsy syndrome	3.38e-05	0.000267	CcSEcCtD
Brinzolamide—Headache—Felbamate—epilepsy syndrome	3.38e-05	0.000267	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	3.38e-05	0.000267	CcSEcCtD
Brinzolamide—Cardiac disorder—Topiramate—epilepsy syndrome	3.38e-05	0.000267	CcSEcCtD
Brinzolamide—Dizziness—Clonazepam—epilepsy syndrome	3.37e-05	0.000266	CcSEcCtD
Brinzolamide—Nausea—Vigabatrin—epilepsy syndrome	3.36e-05	0.000266	CcSEcCtD
Brinzolamide—Vomiting—Zonisamide—epilepsy syndrome	3.36e-05	0.000265	CcSEcCtD
Brinzolamide—Insomnia—Valproic Acid—epilepsy syndrome	3.35e-05	0.000265	CcSEcCtD
Brinzolamide—Asthenia—Lamotrigine—epilepsy syndrome	3.35e-05	0.000264	CcSEcCtD
Brinzolamide—Dizziness—Phenytoin—epilepsy syndrome	3.34e-05	0.000264	CcSEcCtD
Brinzolamide—Rash—Zonisamide—epilepsy syndrome	3.33e-05	0.000263	CcSEcCtD
Brinzolamide—Infection—Pregabalin—epilepsy syndrome	3.33e-05	0.000263	CcSEcCtD
Brinzolamide—Paraesthesia—Valproic Acid—epilepsy syndrome	3.33e-05	0.000263	CcSEcCtD
Brinzolamide—Palpitations—Gabapentin—epilepsy syndrome	3.33e-05	0.000263	CcSEcCtD
Brinzolamide—Dermatitis—Zonisamide—epilepsy syndrome	3.33e-05	0.000263	CcSEcCtD
Brinzolamide—Dizziness—Oxcarbazepine—epilepsy syndrome	3.33e-05	0.000263	CcSEcCtD
Brinzolamide—Nausea—Diazepam—epilepsy syndrome	3.31e-05	0.000262	CcSEcCtD
Brinzolamide—Headache—Zonisamide—epilepsy syndrome	3.31e-05	0.000261	CcSEcCtD
Brinzolamide—Dyspnoea—Valproic Acid—epilepsy syndrome	3.31e-05	0.000261	CcSEcCtD
Brinzolamide—Diarrhoea—Carbamazepine—epilepsy syndrome	3.3e-05	0.000261	CcSEcCtD
Brinzolamide—Angiopathy—Topiramate—epilepsy syndrome	3.3e-05	0.000261	CcSEcCtD
Brinzolamide—Pruritus—Lamotrigine—epilepsy syndrome	3.3e-05	0.000261	CcSEcCtD
Brinzolamide—Somnolence—Valproic Acid—epilepsy syndrome	3.3e-05	0.00026	CcSEcCtD
Brinzolamide—Immune system disorder—Topiramate—epilepsy syndrome	3.29e-05	0.00026	CcSEcCtD
Brinzolamide—Nervous system disorder—Pregabalin—epilepsy syndrome	3.29e-05	0.00026	CcSEcCtD
Brinzolamide—Cough—Gabapentin—epilepsy syndrome	3.29e-05	0.00026	CcSEcCtD
Brinzolamide—Mediastinal disorder—Topiramate—epilepsy syndrome	3.28e-05	0.000259	CcSEcCtD
Brinzolamide—Tachycardia—Pregabalin—epilepsy syndrome	3.27e-05	0.000258	CcSEcCtD
Brinzolamide—Dyspepsia—Valproic Acid—epilepsy syndrome	3.26e-05	0.000258	CcSEcCtD
Brinzolamide—Skin disorder—Pregabalin—epilepsy syndrome	3.26e-05	0.000257	CcSEcCtD
Brinzolamide—Hypertension—Gabapentin—epilepsy syndrome	3.25e-05	0.000257	CcSEcCtD
Brinzolamide—Vomiting—Clonazepam—epilepsy syndrome	3.24e-05	0.000256	CcSEcCtD
Brinzolamide—Decreased appetite—Valproic Acid—epilepsy syndrome	3.22e-05	0.000255	CcSEcCtD
Brinzolamide—Alopecia—Topiramate—epilepsy syndrome	3.22e-05	0.000254	CcSEcCtD
Brinzolamide—Vomiting—Phenytoin—epilepsy syndrome	3.22e-05	0.000254	CcSEcCtD
Brinzolamide—Rash—Clonazepam—epilepsy syndrome	3.21e-05	0.000254	CcSEcCtD
Brinzolamide—Dermatitis—Clonazepam—epilepsy syndrome	3.21e-05	0.000253	CcSEcCtD
Brinzolamide—Arthralgia—Gabapentin—epilepsy syndrome	3.21e-05	0.000253	CcSEcCtD
Brinzolamide—Myalgia—Gabapentin—epilepsy syndrome	3.21e-05	0.000253	CcSEcCtD
Brinzolamide—Chest pain—Gabapentin—epilepsy syndrome	3.21e-05	0.000253	CcSEcCtD
Brinzolamide—Nausea—Felbamate—epilepsy syndrome	3.21e-05	0.000253	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	3.2e-05	0.000253	CcSEcCtD
Brinzolamide—Vomiting—Oxcarbazepine—epilepsy syndrome	3.2e-05	0.000253	CcSEcCtD
Brinzolamide—Fatigue—Valproic Acid—epilepsy syndrome	3.2e-05	0.000252	CcSEcCtD
Brinzolamide—Dizziness—Carbamazepine—epilepsy syndrome	3.19e-05	0.000252	CcSEcCtD
Brinzolamide—Diarrhoea—Lamotrigine—epilepsy syndrome	3.19e-05	0.000252	CcSEcCtD
Brinzolamide—Headache—Clonazepam—epilepsy syndrome	3.19e-05	0.000252	CcSEcCtD
Brinzolamide—Rash—Phenytoin—epilepsy syndrome	3.19e-05	0.000252	CcSEcCtD
Brinzolamide—Mental disorder—Topiramate—epilepsy syndrome	3.19e-05	0.000252	CcSEcCtD
Brinzolamide—Dermatitis—Phenytoin—epilepsy syndrome	3.19e-05	0.000252	CcSEcCtD
Brinzolamide—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	3.18e-05	0.000252	CcSEcCtD
Brinzolamide—Rash—Oxcarbazepine—epilepsy syndrome	3.17e-05	0.000251	CcSEcCtD
Brinzolamide—Pain—Valproic Acid—epilepsy syndrome	3.17e-05	0.00025	CcSEcCtD
Brinzolamide—Dermatitis—Oxcarbazepine—epilepsy syndrome	3.17e-05	0.00025	CcSEcCtD
Brinzolamide—Headache—Phenytoin—epilepsy syndrome	3.17e-05	0.00025	CcSEcCtD
Brinzolamide—Malnutrition—Topiramate—epilepsy syndrome	3.17e-05	0.00025	CcSEcCtD
Brinzolamide—Erythema—Topiramate—epilepsy syndrome	3.17e-05	0.00025	CcSEcCtD
Brinzolamide—Discomfort—Gabapentin—epilepsy syndrome	3.17e-05	0.00025	CcSEcCtD
Brinzolamide—Headache—Oxcarbazepine—epilepsy syndrome	3.15e-05	0.000249	CcSEcCtD
Brinzolamide—Nausea—Zonisamide—epilepsy syndrome	3.14e-05	0.000248	CcSEcCtD
Brinzolamide—Dry mouth—Gabapentin—epilepsy syndrome	3.14e-05	0.000248	CcSEcCtD
Brinzolamide—Hypotension—Pregabalin—epilepsy syndrome	3.13e-05	0.000247	CcSEcCtD
Brinzolamide—Flatulence—Topiramate—epilepsy syndrome	3.12e-05	0.000247	CcSEcCtD
Brinzolamide—Tension—Topiramate—epilepsy syndrome	3.11e-05	0.000246	CcSEcCtD
Brinzolamide—Dysgeusia—Topiramate—epilepsy syndrome	3.1e-05	0.000245	CcSEcCtD
Brinzolamide—Dizziness—Lamotrigine—epilepsy syndrome	3.09e-05	0.000244	CcSEcCtD
Brinzolamide—Nervousness—Topiramate—epilepsy syndrome	3.08e-05	0.000243	CcSEcCtD
Brinzolamide—Vomiting—Carbamazepine—epilepsy syndrome	3.07e-05	0.000242	CcSEcCtD
Brinzolamide—Back pain—Topiramate—epilepsy syndrome	3.06e-05	0.000242	CcSEcCtD
Brinzolamide—Feeling abnormal—Valproic Acid—epilepsy syndrome	3.06e-05	0.000241	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	3.05e-05	0.000241	CcSEcCtD
Brinzolamide—Infection—Gabapentin—epilepsy syndrome	3.05e-05	0.000241	CcSEcCtD
Brinzolamide—Muscle spasms—Topiramate—epilepsy syndrome	3.05e-05	0.000241	CcSEcCtD
Brinzolamide—Rash—Carbamazepine—epilepsy syndrome	3.04e-05	0.00024	CcSEcCtD
Brinzolamide—Dermatitis—Carbamazepine—epilepsy syndrome	3.04e-05	0.00024	CcSEcCtD
Brinzolamide—Insomnia—Pregabalin—epilepsy syndrome	3.03e-05	0.000239	CcSEcCtD
Brinzolamide—Nausea—Clonazepam—epilepsy syndrome	3.02e-05	0.000239	CcSEcCtD
Brinzolamide—Headache—Carbamazepine—epilepsy syndrome	3.02e-05	0.000239	CcSEcCtD
Brinzolamide—Nervous system disorder—Gabapentin—epilepsy syndrome	3.01e-05	0.000238	CcSEcCtD
Brinzolamide—Paraesthesia—Pregabalin—epilepsy syndrome	3.01e-05	0.000238	CcSEcCtD
Brinzolamide—Nausea—Phenytoin—epilepsy syndrome	3e-05	0.000237	CcSEcCtD
Brinzolamide—Tachycardia—Gabapentin—epilepsy syndrome	3e-05	0.000237	CcSEcCtD
Brinzolamide—Dyspnoea—Pregabalin—epilepsy syndrome	2.99e-05	0.000236	CcSEcCtD
Brinzolamide—Nausea—Oxcarbazepine—epilepsy syndrome	2.99e-05	0.000236	CcSEcCtD
Brinzolamide—Vision blurred—Topiramate—epilepsy syndrome	2.99e-05	0.000236	CcSEcCtD
Brinzolamide—Skin disorder—Gabapentin—epilepsy syndrome	2.99e-05	0.000236	CcSEcCtD
Brinzolamide—Somnolence—Pregabalin—epilepsy syndrome	2.98e-05	0.000235	CcSEcCtD
Brinzolamide—Tremor—Topiramate—epilepsy syndrome	2.97e-05	0.000234	CcSEcCtD
Brinzolamide—Vomiting—Lamotrigine—epilepsy syndrome	2.97e-05	0.000234	CcSEcCtD
Brinzolamide—Urticaria—Valproic Acid—epilepsy syndrome	2.95e-05	0.000233	CcSEcCtD
Brinzolamide—Rash—Lamotrigine—epilepsy syndrome	2.94e-05	0.000232	CcSEcCtD
Brinzolamide—Ill-defined disorder—Topiramate—epilepsy syndrome	2.94e-05	0.000232	CcSEcCtD
Brinzolamide—Dermatitis—Lamotrigine—epilepsy syndrome	2.94e-05	0.000232	CcSEcCtD
Brinzolamide—Headache—Lamotrigine—epilepsy syndrome	2.92e-05	0.000231	CcSEcCtD
Brinzolamide—Decreased appetite—Pregabalin—epilepsy syndrome	2.91e-05	0.00023	CcSEcCtD
Brinzolamide—Agitation—Topiramate—epilepsy syndrome	2.91e-05	0.00023	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	2.89e-05	0.000229	CcSEcCtD
Brinzolamide—Fatigue—Pregabalin—epilepsy syndrome	2.89e-05	0.000228	CcSEcCtD
Brinzolamide—Hypotension—Gabapentin—epilepsy syndrome	2.87e-05	0.000227	CcSEcCtD
Brinzolamide—Nausea—Carbamazepine—epilepsy syndrome	2.87e-05	0.000227	CcSEcCtD
Brinzolamide—Pain—Pregabalin—epilepsy syndrome	2.87e-05	0.000226	CcSEcCtD
Brinzolamide—Malaise—Topiramate—epilepsy syndrome	2.86e-05	0.000226	CcSEcCtD
Brinzolamide—Vertigo—Topiramate—epilepsy syndrome	2.85e-05	0.000225	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	2.8e-05	0.000221	CcSEcCtD
Brinzolamide—Palpitations—Topiramate—epilepsy syndrome	2.8e-05	0.000221	CcSEcCtD
Brinzolamide—Insomnia—Gabapentin—epilepsy syndrome	2.78e-05	0.00022	CcSEcCtD
Brinzolamide—Nausea—Lamotrigine—epilepsy syndrome	2.77e-05	0.000219	CcSEcCtD
Brinzolamide—Cough—Topiramate—epilepsy syndrome	2.76e-05	0.000218	CcSEcCtD
Brinzolamide—Feeling abnormal—Pregabalin—epilepsy syndrome	2.76e-05	0.000218	CcSEcCtD
Brinzolamide—Paraesthesia—Gabapentin—epilepsy syndrome	2.76e-05	0.000218	CcSEcCtD
Brinzolamide—Dyspnoea—Gabapentin—epilepsy syndrome	2.74e-05	0.000216	CcSEcCtD
Brinzolamide—Hypertension—Topiramate—epilepsy syndrome	2.74e-05	0.000216	CcSEcCtD
Brinzolamide—Somnolence—Gabapentin—epilepsy syndrome	2.73e-05	0.000216	CcSEcCtD
Brinzolamide—Hypersensitivity—Valproic Acid—epilepsy syndrome	2.73e-05	0.000216	CcSEcCtD
Brinzolamide—Dyspepsia—Gabapentin—epilepsy syndrome	2.71e-05	0.000214	CcSEcCtD
Brinzolamide—Chest pain—Topiramate—epilepsy syndrome	2.7e-05	0.000213	CcSEcCtD
Brinzolamide—Arthralgia—Topiramate—epilepsy syndrome	2.7e-05	0.000213	CcSEcCtD
Brinzolamide—Myalgia—Topiramate—epilepsy syndrome	2.7e-05	0.000213	CcSEcCtD
Brinzolamide—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	2.68e-05	0.000212	CcSEcCtD
Brinzolamide—Decreased appetite—Gabapentin—epilepsy syndrome	2.67e-05	0.000211	CcSEcCtD
Brinzolamide—Discomfort—Topiramate—epilepsy syndrome	2.67e-05	0.000211	CcSEcCtD
Brinzolamide—Urticaria—Pregabalin—epilepsy syndrome	2.66e-05	0.00021	CcSEcCtD
Brinzolamide—Asthenia—Valproic Acid—epilepsy syndrome	2.66e-05	0.00021	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	2.65e-05	0.00021	CcSEcCtD
Brinzolamide—Fatigue—Gabapentin—epilepsy syndrome	2.65e-05	0.000209	CcSEcCtD
Brinzolamide—Dry mouth—Topiramate—epilepsy syndrome	2.64e-05	0.000208	CcSEcCtD
Brinzolamide—Pain—Gabapentin—epilepsy syndrome	2.63e-05	0.000208	CcSEcCtD
Brinzolamide—Pruritus—Valproic Acid—epilepsy syndrome	2.62e-05	0.000207	CcSEcCtD
Brinzolamide—Infection—Topiramate—epilepsy syndrome	2.57e-05	0.000203	CcSEcCtD
Brinzolamide—Diarrhoea—Valproic Acid—epilepsy syndrome	2.54e-05	0.0002	CcSEcCtD
Brinzolamide—Nervous system disorder—Topiramate—epilepsy syndrome	2.54e-05	0.0002	CcSEcCtD
Brinzolamide—Feeling abnormal—Gabapentin—epilepsy syndrome	2.53e-05	0.0002	CcSEcCtD
Brinzolamide—Tachycardia—Topiramate—epilepsy syndrome	2.52e-05	0.000199	CcSEcCtD
Brinzolamide—Skin disorder—Topiramate—epilepsy syndrome	2.51e-05	0.000198	CcSEcCtD
Brinzolamide—Hypersensitivity—Pregabalin—epilepsy syndrome	2.47e-05	0.000195	CcSEcCtD
Brinzolamide—Dizziness—Valproic Acid—epilepsy syndrome	2.45e-05	0.000194	CcSEcCtD
Brinzolamide—Urticaria—Gabapentin—epilepsy syndrome	2.44e-05	0.000193	CcSEcCtD
Brinzolamide—Hypotension—Topiramate—epilepsy syndrome	2.42e-05	0.000191	CcSEcCtD
Brinzolamide—Asthenia—Pregabalin—epilepsy syndrome	2.4e-05	0.00019	CcSEcCtD
Brinzolamide—Pruritus—Pregabalin—epilepsy syndrome	2.37e-05	0.000187	CcSEcCtD
Brinzolamide—Vomiting—Valproic Acid—epilepsy syndrome	2.36e-05	0.000186	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	2.36e-05	0.000186	CcSEcCtD
Brinzolamide—Insomnia—Topiramate—epilepsy syndrome	2.34e-05	0.000185	CcSEcCtD
Brinzolamide—Rash—Valproic Acid—epilepsy syndrome	2.34e-05	0.000185	CcSEcCtD
Brinzolamide—Dermatitis—Valproic Acid—epilepsy syndrome	2.34e-05	0.000184	CcSEcCtD
Brinzolamide—Headache—Valproic Acid—epilepsy syndrome	2.32e-05	0.000183	CcSEcCtD
Brinzolamide—Paraesthesia—Topiramate—epilepsy syndrome	2.32e-05	0.000183	CcSEcCtD
Brinzolamide—Dyspnoea—Topiramate—epilepsy syndrome	2.31e-05	0.000182	CcSEcCtD
Brinzolamide—Somnolence—Topiramate—epilepsy syndrome	2.3e-05	0.000182	CcSEcCtD
Brinzolamide—Diarrhoea—Pregabalin—epilepsy syndrome	2.29e-05	0.000181	CcSEcCtD
Brinzolamide—Dyspepsia—Topiramate—epilepsy syndrome	2.28e-05	0.00018	CcSEcCtD
Brinzolamide—Hypersensitivity—Gabapentin—epilepsy syndrome	2.26e-05	0.000179	CcSEcCtD
Brinzolamide—Decreased appetite—Topiramate—epilepsy syndrome	2.25e-05	0.000178	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Topiramate—epilepsy syndrome	2.23e-05	0.000176	CcSEcCtD
Brinzolamide—Fatigue—Topiramate—epilepsy syndrome	2.23e-05	0.000176	CcSEcCtD
Brinzolamide—Dizziness—Pregabalin—epilepsy syndrome	2.22e-05	0.000175	CcSEcCtD
Brinzolamide—Pain—Topiramate—epilepsy syndrome	2.21e-05	0.000175	CcSEcCtD
Brinzolamide—Asthenia—Gabapentin—epilepsy syndrome	2.21e-05	0.000174	CcSEcCtD
Brinzolamide—Nausea—Valproic Acid—epilepsy syndrome	2.2e-05	0.000174	CcSEcCtD
Brinzolamide—Pruritus—Gabapentin—epilepsy syndrome	2.17e-05	0.000172	CcSEcCtD
Brinzolamide—Vomiting—Pregabalin—epilepsy syndrome	2.13e-05	0.000168	CcSEcCtD
Brinzolamide—Feeling abnormal—Topiramate—epilepsy syndrome	2.13e-05	0.000168	CcSEcCtD
Brinzolamide—Rash—Pregabalin—epilepsy syndrome	2.11e-05	0.000167	CcSEcCtD
Brinzolamide—Dermatitis—Pregabalin—epilepsy syndrome	2.11e-05	0.000167	CcSEcCtD
Brinzolamide—Diarrhoea—Gabapentin—epilepsy syndrome	2.1e-05	0.000166	CcSEcCtD
Brinzolamide—Headache—Pregabalin—epilepsy syndrome	2.1e-05	0.000166	CcSEcCtD
Brinzolamide—Urticaria—Topiramate—epilepsy syndrome	2.05e-05	0.000162	CcSEcCtD
Brinzolamide—Dizziness—Gabapentin—epilepsy syndrome	2.03e-05	0.000161	CcSEcCtD
Brinzolamide—Nausea—Pregabalin—epilepsy syndrome	1.99e-05	0.000157	CcSEcCtD
Brinzolamide—Vomiting—Gabapentin—epilepsy syndrome	1.95e-05	0.000154	CcSEcCtD
Brinzolamide—Rash—Gabapentin—epilepsy syndrome	1.94e-05	0.000153	CcSEcCtD
Brinzolamide—Dermatitis—Gabapentin—epilepsy syndrome	1.94e-05	0.000153	CcSEcCtD
Brinzolamide—Headache—Gabapentin—epilepsy syndrome	1.93e-05	0.000152	CcSEcCtD
Brinzolamide—Hypersensitivity—Topiramate—epilepsy syndrome	1.91e-05	0.00015	CcSEcCtD
Brinzolamide—Asthenia—Topiramate—epilepsy syndrome	1.86e-05	0.000147	CcSEcCtD
Brinzolamide—Pruritus—Topiramate—epilepsy syndrome	1.83e-05	0.000145	CcSEcCtD
Brinzolamide—Nausea—Gabapentin—epilepsy syndrome	1.83e-05	0.000144	CcSEcCtD
Brinzolamide—Diarrhoea—Topiramate—epilepsy syndrome	1.77e-05	0.00014	CcSEcCtD
Brinzolamide—Dizziness—Topiramate—epilepsy syndrome	1.71e-05	0.000135	CcSEcCtD
Brinzolamide—Vomiting—Topiramate—epilepsy syndrome	1.64e-05	0.00013	CcSEcCtD
Brinzolamide—Rash—Topiramate—epilepsy syndrome	1.63e-05	0.000129	CcSEcCtD
Brinzolamide—Dermatitis—Topiramate—epilepsy syndrome	1.63e-05	0.000129	CcSEcCtD
Brinzolamide—Headache—Topiramate—epilepsy syndrome	1.62e-05	0.000128	CcSEcCtD
Brinzolamide—Nausea—Topiramate—epilepsy syndrome	1.54e-05	0.000121	CcSEcCtD
Brinzolamide—CA4—Metabolism—KCNJ11—epilepsy syndrome	1.49e-05	0.000213	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—CYP2C19—epilepsy syndrome	1.49e-05	0.000213	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—CYP11A1—epilepsy syndrome	1.48e-05	0.000211	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—CACNA1D—epilepsy syndrome	1.47e-05	0.00021	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—ADRA2A—epilepsy syndrome	1.47e-05	0.00021	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—ADRA2A—epilepsy syndrome	1.47e-05	0.00021	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—BCHE—epilepsy syndrome	1.46e-05	0.000209	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—BCHE—epilepsy syndrome	1.46e-05	0.000209	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—CYP2D6—epilepsy syndrome	1.44e-05	0.000206	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—CYP2D6—epilepsy syndrome	1.44e-05	0.000206	CbGpPWpGaD
Brinzolamide—CA9—Cellular responses to stress—RELA—epilepsy syndrome	1.44e-05	0.000205	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—KCNJ11—epilepsy syndrome	1.43e-05	0.000205	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—SLC2A1—epilepsy syndrome	1.43e-05	0.000205	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—CHRM3—epilepsy syndrome	1.43e-05	0.000205	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—PLCB1—epilepsy syndrome	1.42e-05	0.000202	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—TH—epilepsy syndrome	1.41e-05	0.000202	CbGpPWpGaD
Brinzolamide—CA9—Cellular responses to stress—MTOR—epilepsy syndrome	1.41e-05	0.000201	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—SLC2A1—epilepsy syndrome	1.4e-05	0.000199	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—SLC2A1—epilepsy syndrome	1.4e-05	0.000199	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—PLCB1—epilepsy syndrome	1.38e-05	0.000197	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—PLCB1—epilepsy syndrome	1.38e-05	0.000197	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—TH—epilepsy syndrome	1.38e-05	0.000197	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—TH—epilepsy syndrome	1.38e-05	0.000197	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—TXNRD1—epilepsy syndrome	1.37e-05	0.000196	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—CHRM3—epilepsy syndrome	1.37e-05	0.000196	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—KCNJ11—epilepsy syndrome	1.37e-05	0.000196	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—ADRA2A—epilepsy syndrome	1.37e-05	0.000196	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—ADRA2A—epilepsy syndrome	1.37e-05	0.000196	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—BCHE—epilepsy syndrome	1.37e-05	0.000195	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—BCHE—epilepsy syndrome	1.37e-05	0.000195	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—CYP2D6—epilepsy syndrome	1.33e-05	0.000191	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—AQP1—epilepsy syndrome	1.33e-05	0.000191	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—SLC2A1—epilepsy syndrome	1.3e-05	0.000186	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—SLC2A1—epilepsy syndrome	1.3e-05	0.000186	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—PLCB1—epilepsy syndrome	1.29e-05	0.000184	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—PLCB1—epilepsy syndrome	1.29e-05	0.000184	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—TH—epilepsy syndrome	1.28e-05	0.000183	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—TH—epilepsy syndrome	1.28e-05	0.000183	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—ADRA2A—epilepsy syndrome	1.27e-05	0.000182	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—BCHE—epilepsy syndrome	1.27e-05	0.000181	CbGpPWpGaD
Brinzolamide—CA9—Cellular responses to stress—JUN—epilepsy syndrome	1.26e-05	0.00018	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—ABCG2—epilepsy syndrome	1.22e-05	0.000174	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—CHRM3—epilepsy syndrome	1.21e-05	0.000172	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—KCNJ11—epilepsy syndrome	1.21e-05	0.000172	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—SLC2A1—epilepsy syndrome	1.21e-05	0.000172	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—PLCB1—epilepsy syndrome	1.19e-05	0.000171	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—TH—epilepsy syndrome	1.19e-05	0.00017	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—CYP2C19—epilepsy syndrome	1.19e-05	0.00017	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—CYP11A1—epilepsy syndrome	1.18e-05	0.000168	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—HMOX1—epilepsy syndrome	1.18e-05	0.000168	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—ABCG2—epilepsy syndrome	1.17e-05	0.000167	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—CAT—epilepsy syndrome	1.16e-05	0.000166	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—HMOX1—epilepsy syndrome	1.15e-05	0.000164	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—HMOX1—epilepsy syndrome	1.15e-05	0.000164	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—CYP2C19—epilepsy syndrome	1.14e-05	0.000163	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—CAT—epilepsy syndrome	1.13e-05	0.000162	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—CAT—epilepsy syndrome	1.13e-05	0.000162	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—ABCB1—epilepsy syndrome	1.13e-05	0.000162	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—CYP11A1—epilepsy syndrome	1.13e-05	0.000162	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—ABCG2—epilepsy syndrome	1.12e-05	0.00016	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—ABCB1—epilepsy syndrome	1.1e-05	0.000157	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—ABCB1—epilepsy syndrome	1.1e-05	0.000157	CbGpPWpGaD
Brinzolamide—CA9—Cellular responses to stress—VEGFA—epilepsy syndrome	1.1e-05	0.000157	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—CYP2C19—epilepsy syndrome	1.09e-05	0.000156	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—CYP11A1—epilepsy syndrome	1.08e-05	0.000155	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—HMOX1—epilepsy syndrome	1.07e-05	0.000153	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—HMOX1—epilepsy syndrome	1.07e-05	0.000153	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—CYP2D6—epilepsy syndrome	1.06e-05	0.000152	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—CAT—epilepsy syndrome	1.06e-05	0.000151	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—CAT—epilepsy syndrome	1.06e-05	0.000151	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—GPX1—epilepsy syndrome	1.05e-05	0.00015	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—ABCB1—epilepsy syndrome	1.03e-05	0.000147	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—ABCB1—epilepsy syndrome	1.03e-05	0.000147	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—GPX1—epilepsy syndrome	1.02e-05	0.000146	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—GPX1—epilepsy syndrome	1.02e-05	0.000146	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—CYP2D6—epilepsy syndrome	1.02e-05	0.000146	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—ADRA2A—epilepsy syndrome	1.01e-05	0.000145	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—BCHE—epilepsy syndrome	1.01e-05	0.000144	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—HMOX1—epilepsy syndrome	9.93e-06	0.000142	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—ABCG2—epilepsy syndrome	9.84e-06	0.000141	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—CAT—epilepsy syndrome	9.8e-06	0.00014	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—CYP2D6—epilepsy syndrome	9.78e-06	0.00014	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—ADRA2A—epilepsy syndrome	9.71e-06	0.000139	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—BCHE—epilepsy syndrome	9.67e-06	0.000138	CbGpPWpGaD
Brinzolamide—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—epilepsy syndrome	9.63e-06	0.000138	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—SLC2A1—epilepsy syndrome	9.63e-06	0.000138	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—CYP2C19—epilepsy syndrome	9.59e-06	0.000137	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—GPX1—epilepsy syndrome	9.56e-06	0.000137	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—GPX1—epilepsy syndrome	9.56e-06	0.000137	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—CYP11A1—epilepsy syndrome	9.53e-06	0.000136	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—ABCB1—epilepsy syndrome	9.53e-06	0.000136	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—PLCB1—epilepsy syndrome	9.52e-06	0.000136	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—TH—epilepsy syndrome	9.49e-06	0.000136	CbGpPWpGaD
Brinzolamide—CYP3A4—Biological oxidations—CYP2C19—epilepsy syndrome	9.44e-06	0.000135	CbGpPWpGaD
Brinzolamide—CYP3A4—Biological oxidations—CYP11A1—epilepsy syndrome	9.38e-06	0.000134	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—ADRA2A—epilepsy syndrome	9.31e-06	0.000133	CbGpPWpGaD
Brinzolamide—CYP3A4—Metapathway biotransformation—CYP2C19—epilepsy syndrome	9.31e-06	0.000133	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—BCHE—epilepsy syndrome	9.27e-06	0.000133	CbGpPWpGaD
Brinzolamide—CYP3A4—Metapathway biotransformation—CYP11A1—epilepsy syndrome	9.25e-06	0.000132	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—SLC2A1—epilepsy syndrome	9.23e-06	0.000132	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—AGT—epilepsy syndrome	9.22e-06	0.000132	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—PLCB1—epilepsy syndrome	9.13e-06	0.00013	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—TH—epilepsy syndrome	9.09e-06	0.00013	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—APOE—epilepsy syndrome	9.03e-06	0.000129	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—AGT—epilepsy syndrome	8.98e-06	0.000128	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—AGT—epilepsy syndrome	8.98e-06	0.000128	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—GPX1—epilepsy syndrome	8.86e-06	0.000127	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—SLC2A1—epilepsy syndrome	8.85e-06	0.000126	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—APOE—epilepsy syndrome	8.8e-06	0.000126	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—APOE—epilepsy syndrome	8.8e-06	0.000126	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—PLCB1—epilepsy syndrome	8.75e-06	0.000125	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—TH—epilepsy syndrome	8.72e-06	0.000125	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—CYP2D6—epilepsy syndrome	8.6e-06	0.000123	CbGpPWpGaD
Brinzolamide—CYP3A4—Biological oxidations—CYP2D6—epilepsy syndrome	8.47e-06	0.000121	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—AGT—epilepsy syndrome	8.39e-06	0.00012	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—AGT—epilepsy syndrome	8.39e-06	0.00012	CbGpPWpGaD
Brinzolamide—CYP3A4—Metapathway biotransformation—CYP2D6—epilepsy syndrome	8.35e-06	0.000119	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—APOE—epilepsy syndrome	8.22e-06	0.000117	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—APOE—epilepsy syndrome	8.22e-06	0.000117	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—ADRA2A—epilepsy syndrome	8.19e-06	0.000117	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—BCHE—epilepsy syndrome	8.15e-06	0.000116	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—HMOX1—epilepsy syndrome	7.92e-06	0.000113	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—CAT—epilepsy syndrome	7.81e-06	0.000112	CbGpPWpGaD
Brinzolamide—CYP3A4—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	7.81e-06	0.000112	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—SLC2A1—epilepsy syndrome	7.78e-06	0.000111	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—AGT—epilepsy syndrome	7.77e-06	0.000111	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—POMC—epilepsy syndrome	7.76e-06	0.000111	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—PLCB1—epilepsy syndrome	7.69e-06	0.00011	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—TH—epilepsy syndrome	7.67e-06	0.00011	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—APOE—epilepsy syndrome	7.61e-06	0.000109	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—ABCB1—epilepsy syndrome	7.6e-06	0.000109	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—HMOX1—epilepsy syndrome	7.59e-06	0.000108	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—POMC—epilepsy syndrome	7.56e-06	0.000108	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—POMC—epilepsy syndrome	7.56e-06	0.000108	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—CAT—epilepsy syndrome	7.49e-06	0.000107	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—ABCB1—epilepsy syndrome	7.29e-06	0.000104	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—HMOX1—epilepsy syndrome	7.28e-06	0.000104	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—CAT—epilepsy syndrome	7.18e-06	0.000103	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—ALB—epilepsy syndrome	7.07e-06	0.000101	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—GPX1—epilepsy syndrome	7.06e-06	0.000101	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—POMC—epilepsy syndrome	7.06e-06	0.000101	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—POMC—epilepsy syndrome	7.06e-06	0.000101	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—ABCB1—epilepsy syndrome	6.99e-06	9.98e-05	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—ALB—epilepsy syndrome	6.89e-06	9.85e-05	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—ALB—epilepsy syndrome	6.89e-06	9.85e-05	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—GPX1—epilepsy syndrome	6.77e-06	9.68e-05	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—POMC—epilepsy syndrome	6.54e-06	9.34e-05	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—GPX1—epilepsy syndrome	6.49e-06	9.28e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—CA13—epilepsy syndrome	6.46e-06	9.22e-05	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—ALB—epilepsy syndrome	6.43e-06	9.19e-05	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—ALB—epilepsy syndrome	6.43e-06	9.19e-05	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—HMOX1—epilepsy syndrome	6.4e-06	9.14e-05	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—CAT—epilepsy syndrome	6.31e-06	9.02e-05	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—AGT—epilepsy syndrome	6.19e-06	8.85e-05	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—PTGS2—epilepsy syndrome	6.19e-06	8.84e-05	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—ABCB1—epilepsy syndrome	6.14e-06	8.77e-05	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—APOE—epilepsy syndrome	6.07e-06	8.67e-05	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—PTGS2—epilepsy syndrome	6.03e-06	8.62e-05	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—PTGS2—epilepsy syndrome	6.03e-06	8.62e-05	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—ALB—epilepsy syndrome	5.96e-06	8.52e-05	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—AGT—epilepsy syndrome	5.94e-06	8.49e-05	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—APOE—epilepsy syndrome	5.82e-06	8.31e-05	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—GPX1—epilepsy syndrome	5.71e-06	8.16e-05	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—AGT—epilepsy syndrome	5.69e-06	8.14e-05	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—PTGS2—epilepsy syndrome	5.63e-06	8.04e-05	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—PTGS2—epilepsy syndrome	5.63e-06	8.04e-05	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—APOE—epilepsy syndrome	5.58e-06	7.97e-05	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—PTGS2—epilepsy syndrome	5.22e-06	7.45e-05	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—POMC—epilepsy syndrome	5.21e-06	7.45e-05	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—AGT—epilepsy syndrome	5.01e-06	7.15e-05	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—POMC—epilepsy syndrome	5e-06	7.14e-05	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—APOE—epilepsy syndrome	4.9e-06	7.01e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—ADK—epilepsy syndrome	4.89e-06	6.99e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—FAR1—epilepsy syndrome	4.89e-06	6.99e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—CERS1—epilepsy syndrome	4.89e-06	6.99e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—GLUD1—epilepsy syndrome	4.89e-06	6.99e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—L2HGDH—epilepsy syndrome	4.89e-06	6.99e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PDXK—epilepsy syndrome	4.89e-06	6.99e-05	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—POMC—epilepsy syndrome	4.79e-06	6.85e-05	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—ALB—epilepsy syndrome	4.75e-06	6.79e-05	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—ALB—epilepsy syndrome	4.56e-06	6.51e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PNPO—epilepsy syndrome	4.48e-06	6.39e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—NHLRC1—epilepsy syndrome	4.48e-06	6.39e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—GAMT—epilepsy syndrome	4.48e-06	6.39e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—EPM2A—epilepsy syndrome	4.48e-06	6.39e-05	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—ALB—epilepsy syndrome	4.37e-06	6.24e-05	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—POMC—epilepsy syndrome	4.21e-06	6.02e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—QDPR—epilepsy syndrome	4.16e-06	5.94e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—CA4—epilepsy syndrome	4.16e-06	5.94e-05	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—PTGS2—epilepsy syndrome	4.16e-06	5.94e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Biological oxidations—POMC—epilepsy syndrome	4.15e-06	5.93e-05	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—PTGS2—epilepsy syndrome	3.99e-06	5.7e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—COX3—epilepsy syndrome	3.91e-06	5.59e-05	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—ALB—epilepsy syndrome	3.84e-06	5.49e-05	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—PTGS2—epilepsy syndrome	3.82e-06	5.46e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PFKL—epilepsy syndrome	3.71e-06	5.3e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—KCNB1—epilepsy syndrome	3.71e-06	5.3e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—CACNA2D2—epilepsy syndrome	3.71e-06	5.3e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—SLCO1A2—epilepsy syndrome	3.71e-06	5.3e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—SLC6A8—epilepsy syndrome	3.71e-06	5.3e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—ATIC—epilepsy syndrome	3.39e-06	4.85e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—UPB1—epilepsy syndrome	3.39e-06	4.85e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—NEU1—epilepsy syndrome	3.39e-06	4.85e-05	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—PTGS2—epilepsy syndrome	3.36e-06	4.8e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—HSD17B4—epilepsy syndrome	3.26e-06	4.66e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PPP1R3C—epilepsy syndrome	3.15e-06	4.51e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—GBE1—epilepsy syndrome	3.15e-06	4.51e-05	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—AKT1—epilepsy syndrome	3.11e-06	4.44e-05	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—AKT1—epilepsy syndrome	3.03e-06	4.33e-05	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—AKT1—epilepsy syndrome	3.03e-06	4.33e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—ASAH1—epilepsy syndrome	2.96e-06	4.24e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—STXBP1—epilepsy syndrome	2.88e-06	4.12e-05	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—AKT1—epilepsy syndrome	2.83e-06	4.04e-05	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—AKT1—epilepsy syndrome	2.83e-06	4.04e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—ALAD—epilepsy syndrome	2.81e-06	4.02e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—NT5E—epilepsy syndrome	2.81e-06	4.02e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—CACNA1A—epilepsy syndrome	2.68e-06	3.83e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—ALDH7A1—epilepsy syndrome	2.68e-06	3.83e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—ST3GAL3—epilepsy syndrome	2.62e-06	3.75e-05	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—AKT1—epilepsy syndrome	2.62e-06	3.74e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—ADSL—epilepsy syndrome	2.57e-06	3.67e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—GLUL—epilepsy syndrome	2.52e-06	3.6e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—CACNA1D—epilepsy syndrome	2.47e-06	3.54e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—TXNRD1—epilepsy syndrome	2.31e-06	3.31e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—AQP1—epilepsy syndrome	2.25e-06	3.21e-05	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—AKT1—epilepsy syndrome	2.09e-06	2.99e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—KCNJ11—epilepsy syndrome	2.03e-06	2.9e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—CHRM3—epilepsy syndrome	2.03e-06	2.9e-05	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—AKT1—epilepsy syndrome	2e-06	2.86e-05	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—AKT1—epilepsy syndrome	1.92e-06	2.75e-05	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—AKT1—epilepsy syndrome	1.69e-06	2.41e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—ABCG2—epilepsy syndrome	1.66e-06	2.37e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—CYP2C19—epilepsy syndrome	1.61e-06	2.31e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—CYP11A1—epilepsy syndrome	1.6e-06	2.29e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—CYP2D6—epilepsy syndrome	1.45e-06	2.07e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—ADRA2A—epilepsy syndrome	1.38e-06	1.97e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—BCHE—epilepsy syndrome	1.37e-06	1.96e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—SLC2A1—epilepsy syndrome	1.31e-06	1.87e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PLCB1—epilepsy syndrome	1.3e-06	1.85e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—TH—epilepsy syndrome	1.29e-06	1.84e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—HMOX1—epilepsy syndrome	1.08e-06	1.54e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—CAT—epilepsy syndrome	1.06e-06	1.52e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—ABCB1—epilepsy syndrome	1.03e-06	1.48e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—GPX1—epilepsy syndrome	9.61e-07	1.37e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—AGT—epilepsy syndrome	8.43e-07	1.2e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—APOE—epilepsy syndrome	8.26e-07	1.18e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—POMC—epilepsy syndrome	7.09e-07	1.01e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—ALB—epilepsy syndrome	6.47e-07	9.24e-06	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PTGS2—epilepsy syndrome	5.66e-07	8.08e-06	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—AKT1—epilepsy syndrome	2.84e-07	4.06e-06	CbGpPWpGaD
